Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval

scientific article published in March 2002

Clinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0009-9120(02)00287-4
P698PubMed publication ID11983349

P50authorNamık DelibaşQ42317073
N DelibaşQ73086372
P2093author name stringIrfan Altuntas
Ramazan Ozcankaya
P2860cites work“Mini-mental state”Q25938989
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer diseaseQ35166007
Lipid peroxidation and free radical scavengers in Alzheimer's diseaseQ41289314
Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's diseaseQ48123841
Differential effects of pharmacological doses of melatonin on malondialdehyde and glutathione levels in young and old ratsQ48289806
Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer typeQ48512132
X-ray diffraction evidence for myelin disorder in brain from humans with Alzheimer's diseaseQ48623622
Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylationQ48922050
Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's diseaseQ53201201
Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging.Q53209733
Malondialdehyde determination as index of lipid peroxidationQ68592283
Superoxide dismutase inhibits the superoxide-driven Fenton reaction at two different levels. Implications for a wider protective roleQ70085728
10 Superoxide dismutase assaysQ70214778
Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type--place of the extracellular glutathione peroxidaseQ71750629
P433issue2
P921main subjectAlzheimer's diseaseQ11081
dementiaQ83030
P304page(s)137-141
P577publication date2002-03-01
P1433published inClinical BiochemistryQ5133749
P1476titleClinical importance of erythrocyte malondialdehyde levels as a marker for cognitive deterioration in patients with dementia of Alzheimer type: a repeated study in 5-year interval
P478volume35

Reverse relations

cites work (P2860)
Q46194803Amyloid peptide inhibits ATP release from human erythrocytes.
Q46800525Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns
Q78344719Current awareness in geriatric psychiatry
Q36331371Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide
Q37198707Differential oxidative stress response in young children and the elderly following exposure to PM(2.5)
Q39903174Effect of a self-care program on oxidative stress and cognitive function in an older Mexican urban-dwelling population
Q45898364Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.
Q37094983Enalapril protects endothelial cells against induced apoptosis in Alzheimer's disease
Q41547214Erythrocytes as Potential Link between Diabetes and Alzheimer's Disease
Q46379315Extremely low frequency electromagnetic field (ELF-EMF) reduces oxidative stress and improves functional and psychological status in ischemic stroke patients.
Q39766604Increased iron and oxidative stress are separately related to cognitive decline in elderly
Q36423066Lipid and protein oxidation in female patients with chronic fatigue syndrome
Q48786427Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder
Q50216785Methionine 35 sulphoxide reduces toxicity of Aβ in red blood cell
Q90277815Oxidative stress in electrohypersensitivity self‑reporting patients: Results of a prospective in vivo investigation with comprehensive molecular analysis
Q47105295Peripheral biomarkers of oxidative stress in aging and Alzheimer's disease
Q27000279Redox control of microglial function: molecular mechanisms and functional significance
Q33641520Role of the membrane in the formation of heme degradation products in red blood cells
Q50682476Serum trace metal levels in Alzheimer's disease and normal control groups.
Q92661943The Erythrocytic Hypothesis of Brain Energy Crisis in Sporadic Alzheimer Disease: Possible Consequences and Supporting Evidence
Q37696521The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease
Q48439988Vascular dysfunction-associated with Alzheimer's disease
Q48606829β-amyloid decreases detectable endothelial nitric oxide synthase in human erythrocytes: a role for membrane acetylcholinesterase.

Search more.